United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 4 minute read Pharma Industry News ESTEVE acquires Caprelsa from Sanofi to boost rare cancer drug portfolio and global specialty focus ESTEVE is acquiring Caprelsa® from Sanofi to expand its rare cancer drug portfolio. The deal boosts ESTEVE's focus on highly specialized treatments. byPallavi MadhirajuJuly 2, 2025